Organization
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA
21 abstracts
Abstract
Historic redlining, modern neighborhood structures, and mortality in children, adolescents, and young adults with cancer.Org: University of Washington, Seattle, WA, University of California, San Francisco, San Francisco, CA, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, San Diego State University Department of Biology, San Diego, CA, Fred Hutchinson Cancer Center, Seattle, WA,
Abstract
Cancer care service use intensity in Medicare Advantage versus traditional Medicare.Org: Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Memorial Sloan Kettering Cancer Center, McDermott+ Consulting, University of Minnesota, George Mason University, Manassas, VA,
Abstract
Overlapping and non-overlapping indications for checkpoint inhibitors in the US.Org: Brigham and Women's Hospital, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Memorial Sloan Kettering Cancer Center,
Abstract
Trends in prices of checkpoint inhibitors in the US, 2016-2023.Org: Brigham and Women's Hospital, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Memorial Sloan Kettering Cancer Center,
Abstract
Use of surgery for de novo metastatic breast cancer (mBC).Org: Stanford Hospital and Clinics, Stanford University School of Medicine, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, University of California, San Francisco,
Abstract
Genomic biomarkers of CNS-specific outcomes in patients with breast cancer brain metastases.Org: Brown University School of Medicine-Rhode Island Hospital, Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Albert Einstein College of Medicine,
Abstract
Trends in pharmaceutical industry payments to US cancer centers, 2014-2021.Org: Memorial Sloan Kettering Cancer Center, US Digital Corps, US General Services Administration, DELFI Diagnostics, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Trends in NCCN enforcement of financial conflict of interest policies for guidelines panelists.Org: Memorial Sloan Kettering Cancer Center, DELFI Diagnostics, University of Florida-Health Cancer Center, Orlando Health, Orlando, FL, Yale University School of Medicine, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Combined modality for localized gastric diffuse large B-cell lymphoma: Long-term outcomes of 50 patients.Org: Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma.Org: Myeloma Service, Department of Medicine, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, New York, NY, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Bridging therapies used in trials testing CAR-T therapies.Org: University of California, San Francisco, Division of Endocrinology, San Francisco, CA, Drexel University College of Medicine, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Diagnosis disclosure patterns among patients with plasma cell disorders.Org: Geisel School of Medicine at Dartmouth, University of Illinois Chicago, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Memorial Sloan Kettering Cancer Center, HealthTree Foundation,
Abstract
Sustained organ preservation in rectal cancer patients treated with total neoadjuvant therapy: Long-term results of the OPRA trial.Org: Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Colorectal Service, Department of Surgery, Brigham and Women's Hospital, Boston, MA, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China,
Abstract
Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS).Org: Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Department of Medicine, Icahn School of Medicine at Mount Sinai, Sarcoma Medical Oncology Service,
Abstract
Impact of neoadjuvant chemo-immunotherapy on surgical outcomes and time to radiation in triple negative breast cancer.Org: Breast Service, Department of Surgery, Brigham and Women's Hospital, Boston, MA, Memorial Sloan Kettering Cancer Center, New York, NY, Biostatistics Service,
Abstract
Organ preservation and total neoadjuvant therapy for rectal cancer: Investigating long course chemoradiation versus short course radiation therapy.Org: Memorial Sloan Kettering Cancer Center, Chung-Ang University College of Medicine, Chung-Ang University Hospital, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers.Org: Breast Service, Department of Surgery, Brigham and Women's Hospital, Boston, MA, Memorial Sloan Kettering Cancer Center, New York, NY, Biostatistics Service,
Abstract
Pathogenic germline variants in patients with endometrial cancer across diverse ancestries.Org: Gynecologic Medical Oncology Service, Department of Medicine, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA,
Abstract
Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.Org: Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Department of Medicine, Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY,
Abstract
Experiences with pain management for survivors of complex cancers: Focus on opioids and cannabis.Org: Memorial Sloan Kettering Cancer Center, MSKCC, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Hartford hospital, Miami Cancer Institute - Baptist Health South Florida,
Abstract
Examining ultrafine particle pollution and lung cancer risk in a large, diverse cohort.Org: Keck School of Medicine of University of Southern California, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, University of Southern California Norris Comprehensive Cancer Center, Department of Environmental and Occupational Health Sciences, University of Washington, Population Sciences in the Pacific Program, University of Hawaiʻi Cancer Center,